| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.09 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |